Vancouver, British Columbia – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) has announced that its application for a management cease trade order (MCTO) under National Policy 12-203 has been accepted by the British Columbia Securities Commission (BCSC). The MCTO was issued effective May 1, 2025, due to the company’s delay in filing its audited annual financial statements and accompanying management’s discussion and analysis for the financial year ended December 31, 2024.
The delay is attributed to the recent transition to a new management team. Beyond Medical Technologies Inc. expects to file the Annual Filings as soon as they are available and by no later than June 30, 2025. The company will issue a news release once the Annual Filings have been filed. Until then, it will comply with the alternative information guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases.
Company Background
Beyond Medical Technologies Inc. is a healthcare technology company that integrates blockchain infrastructure to enhance patient outcomes and operational efficiency across the medical ecosystem.
Forward-Looking Statements
This release includes forward-looking statements within the meaning of applicable Canadian securities laws. These statements reflect the expectations or beliefs of management regarding future events and involve numerous risks and uncertainties. Actual results may differ materially from those suggested in the forward-looking statements. Readers are cautioned not to place undue reliance on these statements.
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
